Cyclerion Therapeutics
AcquiredCyclerion
Cambridge, United States · Founded 2019
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- cyclerion.com
- Last Round
- Venture RoundMay 2023
- Rounds
- 3
- Acquisition Date
- Apr 2019
About
Clinical-stage biopharmaceutical company developing treatments for neuropsychiatric diseases, including CYC-126 for treatment-resistant depression.
Summary
Cyclerion Therapeutics is a Biotech company based in Cambridge, United States, founded in 2019. Its most recent funding was a Venture Round in May 2023. Investors include EcoR1 Capital, Ironwood Pharmaceuticals and Slate Path Capital.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Apr 2026
Sign up to see all 7 events
Funding: Convertible Note through Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cyclerion-therapeutics"><img src="https://indexed.vc/api/badge/company/cyclerion-therapeutics" alt="Cyclerion Therapeutics on Indexed.vc" width="260" height="76" /></a>